17Feb 2020

CORRELATION OFLIPID PROFILE WITH GLYCATED HEMOGLOBIN (HBA1C) IN DIABETIC PATIENTS IN KING ABDULLAH HOSPITAL, BISHA, SAUDI ARABIA

  • Department of Medical Laboratory Sciences, College Of Applied Medical Sciences, University of Bisha. Bisha, 61922. P. O Box 551. Saudi Arabia.
  • Department of Medical Laboratory Sciences, Faculty Of Medical And Medical Sciences, University of Hodeidah, Yemen.
  • Department of Clinical Chemistry, Faculty of Medical Laboratory Sciences, University of El Imam El Mahdi, Kosti, 209 P.O. Box 27711. Sudan.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Background: This study aimed to observe the lipid profile in diabeticpatients and to find out correlation between glycated hemoglobin (HbA1C) and lipid profile. Methods: Lipid profiles, fasting blood sugar and HbA1C values of 100 diabetic patients were studied. Blood samples of 41 male and 59 female diabetic patients were assessed for fasting blood glucose (FBG), total cholesterol, TG, LDL and HDL andHbA1C. Results: The 100 diabetic patients were havingHbA1C mean valuewas 9.1?1.9%. Means of HbA1C, cholesterol, HDL, LDL, and FBG were higher in females than males. In contrast, means of triglycerides and age were lower in female than males. All parameters have positive correlation with HbA1C. Significant correlation of HbA1C levels wereseen with FBG (p<0.01).TGwas having negative correlation with HDL, LDL and FBG. The HDL values of diabetic patients were negatively significantly correlated with age with p value 0.008. LDL levels were significantly correlated with cholesteroland age (p<0.01 and 0.049).About 60% of diabetic patientstheir HDL was >46mg/dl (1.2mmol/L) and >70% were having HDL>30mg/dl (0.8mmol/L). Findings indicate>50% of patients participated in this study may be at low risk, or in a good diabetic control or on medication, since, poor glycemic control in diabetic patients can lead to decreased HDL. Conclusion: Results in this study indicated the need for therapeutic attention for diabetic patients, especially those who are of small ages.Depending on antidiabetic medications only is not enough to treat diabetic patients.

  1. Al-nozha mm1,?al-maatouq ma,?al-mazrou yy,?al-harthi ss,?arafah mr,?khalil mz,?khan nb,?al-khadra a,?al-marzouki k,?nouh ms,?abdullah m,?attas o,?al-shahid ms,?al-mobeireek a.; diabetes mellitus in saudi arabia.. Saudi med j.?2004; 25 (11):1603-10.
  2. Allain CC, Poon IS, Chan CHG, Richmond W. Enzymatic determina?tion of serum total cholesterol. Clin. Chem. 1974; 20:470-71.
  3. Ahmed EM, Mohamed AO, Salih EM, Salih MSM, Idris BE.Assessment of serum lipid profile in Sudanese diabetic patients treated with insulin and/or oral hypoglycemic medications.Journal of natural and medical sciences. 2015; 16(1): 141-150.
  4. Ahmed EM, et al. Lp (a) in Sudanese diabetic patients correlated with glycosylated hemoglobin. International journal of biological and medical research.2014; 5 (2): 4051-4056.
  5. Arshag D M. Dyslipidemia in type 2 diabetes mellitus, Nature Clinical Practice Endocrinology & Metabolism, 2009; 5: 150-159
  6. Ahmed N, Khan J, Siddiqui TS. Frequency of dyslipidemia in type 2 diabetes mellitus in patients of Hazara division. Journal of Ayub Medical College Abbottabad.2008; 20 (2): 51-54.
  7. Bennett HP, Knowler WC, Definition, Classification of Diabetes Mellitus and Glucose Homeostasis. In CR Kahn, GC Weir, GL King, AC Moses, RJ Smith and AM Jacobson editors. Joslin's Diabetes Mellitus, Philadelphia: LWW; 2000,331.
  8. Chan D C., and Watts G F. Apolipoproteins as markers and managers of coronary risk, Journal of Medicine, 2006; 99 (5): 277-287.
  9. Chaturvedi N, Fuller JH, Taskinen MR; EURODIAB PCS Group. Differing associations of lipid and lipoprotein disturbances with the macrovascular and micro vascular complications of Type 2 diabetes. Diabetes Care 2001; 24: 2071-7
  10. Deeg R, Ziegenhorn J. Kinetic enzymatic method for automated determination of total cholesterol in serum. Clin Chem 1983; 29: 1798-802.
  11. Drexel H. reducing risk by raising HDL-cholesterol; the evidence. European Heart Journal Supplements, 2006: 8; 23-29.
  12. EdelamD, Olsen, MK, Dudley T K., Harris A C and Oddone E Z. Utility of HbA1C in predicting diabetes risk, Journal of General Internal Medicine, 2004; 19 (12): 1175-1180.
  13. El-Hazmi M A F, Warsy A S, Al-SwailemA M. Lipids and Related Parameters in Saudi Type II Diabetes Mellitus Patients. Annals of Saudi Medicine, 1999; 19 (4);
  14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concen?tration of LDL-cholesterol. Clin. Chem 1972; 18 (6): 499-515.
  15. Fadlalla EMA, and Mohamed AO. Assessment of Lp (a) in blood sample of Sudanese diabetic patients correlated with glycosylated hemoglobin.Journal of natural and medical sciences. 2014; 15(2): 92-98.
  16. Ginsberg HN, Goldberg LL. Disorders of lipoprotein metabolism. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, et al., editors. Harrison?s Principles of Internal Medicine. Vo1. 2. Ch. 344. New York: McGraw Hill Medical Publishing Division; 2001. p. 2246.
  17. Gordon T, et al. An enzymatic method for the determination of the serum HDL-cholesterol. Am. J. Med 1977; 62: 707-08.
  18. Gligor Ramona et al. Relationship between glycosylated hemoglobin and lipid metabolism in patients with type 2 diabetes. Studia Universitatis ?VasileGoldiş?, SeriaŞtiinţeleVieţii 2011; 21 (2): pp. 313-318
  19. Harvey JN. Diabetic nephropathy BMJ 2002; 325: 59-60.
  20. Irene M Stratton, Amanda I Alder et al., Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35); Brit Med J. 2000 Vol 321 : 405-416
  21. Imani SF, Hashemipour M, Kelishadi R, lipid profile of children with type 1 diabetes compared to control. Advance research yields across atherosclerosis journal; 2006; 2 (1): 36-38.
  22. Jacobs NJ, Van Denmark PJ. Enzymatic determination of serum trig?lycerides. Biochem. Biophys 1960; 88:250-55.
  23. Karar T, Alhammad R.I.S, Abdel Fattah M, Alanzi A, Qureshi S. Relation between glycosylated hemoglobin and lipid and thyroid hormone among patients with type 2 diabetes mellitus at King Abdulaziz Medical City, Riyadh. Journal of National Science, Biology and Medicine. 2015; 6 (Suppl 1): S75?S79.
  24. Khattab, M., Khader, Y. S., AlKhawaldeh, A., Ajlouni, K.? Factors associated with poor glycemic control among patients with Type 2 diabetes, Journal of Diabetes and Its Complications, 2010; 24: 84?89.
  25. Khaw KT, Wareham N, Bingham S, Luben R, Welch A and Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European Prospective Investigation into Cancer in Norfolk. Ann Intern Med 2004; 141: 413-420.
  26. Mohamed Abdulaziz Al Dawish, Asirvatham Alwin Robert, Rim Braham, Ayman Abdallah AlHayek, Abdulghani Al Saeed, Rania Ahmed Ahmed and Fahad Sulaiman Al Sabaan; Diabetes Mellitus in Saudi Arabia: A Review of the Recent Literature.Current Diabetes Reviews, 2016, 12, 1-10.
  27. Mazzone T. Current concepts and controversies in the pathogenesis, prevention, and treatment of the macrovascular complications of diabetes. J Lab Clin Med 2000; 135: 437-43.
  28. .Mohieldein A H, Abdelkarim A M, Osman F M, Abdallah E A, Ali M M. HbA1C as a marker to reduce limb amputation in patient with type 2 diabetes mellitus, Sudan Journal of Medical Science 2008; 3(3):227-232.
  29. Makamto S C, Oben J E, Ngondi J L, Fezeu K L L, Kengne A P, and Mbanya J C. Dietary Control and Lipid Profiles of Type 2 Diabetes Mellitus Patients in Yaounde, Cameroon, Pakistan Journal of Nutrition, 2005; 4 (5): 282-286.
  30. Mohammed MEA, Fadlalla, EMA, Mohamed AO. Prolonged hyperglycemia in diabetic patients, its effect on inducing dyslipidemia and increasing the risk of cardiovascular disease. International journal of biological and medical research.2014; 5 (2): 3964-3469
  31. National Cholesterol Education Program (NCEP). Expert panel on the detection, evaluation and the treatment of high blood cholesterol
  32. Obot A S, Usoro CAO,Nsonwu-Anyanwu A C, Egbe E R, Ekott J U and UsoroA J. Adiponectin and cardiovascular risk factors in relation with glycemic control in type 2 diabetics, International Journal of Research in Medical Sciences, 2013; 1(4):563-570
  33. Powers AC, Diabetes Mellitus: Complications. In DL Kasper, AS Fauci, DL Longo, SL Hauser, JL Jameson and J Loscalzo editors. Harrison's Principles of Internal Medicine. New York: McGraw-Hill Education; 2015. p.2399.
  34. Ram Vinod Mahato et al. Association between glycaemic control and serum lipid profile in type 2 diabetic patients: Glycated haemoglobin as a dual biomarker. Biomedical Research 2011; 22 (3): 375-380.
  35. Ramprasad G, and Frederick F S. Dyslipidemia in type 2diabetes mellitus, Current diabetes report, 2007; 7 (3): 228-234.
  36. Syvanne M, Kahri J, Vitranen K S, Taskinen M R. HDLs Containing Apolipoproteins A-I and AII (Lp A-I:A-II) as Markers of Coronary Artery Disease in Men with Non? Insulin- Dependent Diabetes Mellitus. Circulation, 1995; 92: 364-370.
  37. Shen G X. Lipid Disorders in Diabetes Mellitus and Current Management, Current Pharmaceutical Analysis, 2007; 3 (1): 17-24 (8).
  38. Selvin E. Meta-Analysis: Glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Annals of Internal Medicine. 2004; 141: 421.
  39. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004; 14: 421-431.
  40. Trinder P. Determination of blood glucose by using 4-aminophenazone as an oxygen acceptor. J.Clin.Path 1969; 22:246.
  41. Valabhji J and Elkele, R S. Dyslipidemia in type 2 diabetes: epidemiology and biochemistry. The British Journal of Diabetes and Vascular Disease, 2003; 3 (3): 184-89.
  42. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27: 1047-53.
  43. Zhe Yan, Yang Liu, Hui Huang. Association of glycosylated hemoglobin level with lipid ratio and individual lipids in type 2 diabetic patients. Asian Pacific Journal of Tropical Medicine 2012; 469-471.

[Khalil Abdullah Ahmed Khalil and Elsadig Mohamed Ahmed (2020); CORRELATION OFLIPID PROFILE WITH GLYCATED HEMOGLOBIN (HBA1C) IN DIABETIC PATIENTS IN KING ABDULLAH HOSPITAL, BISHA, SAUDI ARABIA Int. J. of Adv. Res. 8 (Feb). 591-599] (ISSN 2320-5407). www.journalijar.com

Khalil Abdullah Ahmed Khalil
Department of medical laboratory sciences, college of applied medical sciences, University of Bisha. Bisha, 61922. P. O Box 551. Saudi Arabia.

DOI:

Article DOI: 10.21474/IJAR01/10490      
DOI URL: https://dx.doi.org/10.21474/IJAR01/10490

Download Full Paper

Download PDF No. of Downloads: 14 | No. of Views: 78